Forest Laboratories And Cypress Bioscience Announce Study Shows Patients Treated With Savella Experience Improvements In Pain And Physical Function
Links shared publicly online about this topic.
- 1,661total visits
Forest Laboratories And Cypress Bioscience Announce Study Shows Patients Treated With Savella Experience Improvements In Pain And Physical Function
Forest laboratories, inc. (nyse: frx) and cypress bioscience, inc. (nasdaq: cypb) announced that savella® (milnacipran hci) 100 mg/day (50 mg twice daily) demonstrated statistically significa
View full resource at medworm.com
Tags: Pain, Fibromyalgia Medication, Neuropathic Pain Medication, Savella, Forest Laboratories
Most Recently Shared on October 21, 2009 at 1:21 pm By:
Forest Laboratories And Cypress Bioscience Announce Study Shows Patients Treated With Savella Experience Improv.. http://bit.ly/4TLAv
Advertisement
